OUR MISSION
Transforming Chemistry,
Enriching Lives
We use real intelligence alongside artificial intelligence to develop clinical candidates for rare, neglected and unmet therapeutic needs, as well as new molecules for consumer product applications.
Whether you’re looking to predict toxicity, visualize molecular data, or build machine learning models, our tools are designed to meet your unique needs.
Not sure which tool is right for you?
Take our short assessment to find the perfect solution for your professional goals.
WHO WE ARE
Innovators in Machine Learning and ADME/Tox
Collaborations Pharmaceuticals, Inc.® is a privately owned company that performs research and development on innovative therapeutics for multiple rare and neglected infectious diseases. We develop and apply our artificial intelligence (AI) software to aid in drug discovery and toxicology assessment as well as to identify and translate early preclinical to clinical stage assets. Our software can also be used to design new molecules with desired properties. This software can be used by pharmaceutical, consumer product, as well as other companies that require chemistry.
>150
Peer Reviewed Publications
9
FDA Orphan Drug Designations
3
FDA Rare Pediatric Drug Designations
1
Patents
Issued
12
Patents
Pending
7
Trademarks
Awarded
WHAT WE DO
No Disease Is Too Small
We apply our machine learning and drug discovery expertise to a wide array of projects both internally and with collaborators. Our toxicology models and read across software could assist your companies sustainable chemistry goals and help you in regulatory filings. We have developed new approaches which can be used to rapidly predict molecular properties for massive DNA-encoded libraries or predict properties for PROTACS. In the process of our work we have raised awareness of the potential for dual use of these AI technologies and therefore have expertise for such evaluations which has caught the attention of government agencies.
FEATURED PUBLICATION
Predicting the Hallucinogenic Potential of Molecules Using Artificial Intelligence
Urbina F, Jones T, Harris JS, Snyder SH, Lane TR, Ekins S, ACS Chem Neurosci. 2024 Aug 02; Article ASAP DOI: 10.1021/acschemneuro.4c00405
The development of new drugs addressing serious mental health and other disorders should avoid the psychedelic experience. Analogs of psychedelic drugs can have clinical utility and are termed “psychoplastogens” [...]
Machine Learning & Generative Design Tools
A platform for the generative design of molecules to create new intellectual property
SEE DETAILS
A suite of tools to curate structure activity data, then build and validate machine learning models
SEE DETAILS
Thousands of machine learning models to help prioritize new uses and off target effects of molecules
SEE DETAILS
A suite of ADME and toxicology machine learning models with optional read across module
SEE DETAILS
Human uptake and efflux transporter machine learning models
SEE DETAILS
Molecule preparation, autocuration and data visualization tools
SEE DETAILS
Acetylcholinesterase machine learning models for multiple species
SEE DETAILS
A comprehensive database of macrolactones and associated biological data
SEE DETAILS
Prediction of the UV-VIS spectra for a molecule from structure alone
SEE DETAILS
A robust chemical inventory tracking software with fine-grained location tracking, advanced querying options, and cross-platform support.
SEE DETAILSHOW WE’RE DIFFERENT
Scientists Focused On Doing Science
Collaborations Pharmaceuticals, Inc.® is a privately owned company that performs research and development. We can apply our artificial intelligence (AI) software to aid your company in solving challenges you may encounter. Our software can be used by pharmaceutical, agrochemical, consumer product companies and anyone interested in chemistry.